CVAS-an interesting california-based biotech company here Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CVAS-an interesting california-based biotech company here

CVAS 0.000400

0.0%

Oct 7 9:32 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: keokalani'nui who wrote (44)	7/24/2001 8:59:33 AM
From: Miljenko Zuanic	Read Replies (1) of 126

This morning news: biz.yahoo.com <<The increased operating expenses in the second quarter and year-to-date in 2001 were primarily attributable to the recently completed manufacturing of the Company's proprietary anticoagulant drug candidate, rNAPc2 and, as such, will not recur. The increased research and development expenses are also attributable to an increase in research activities and headcount associated with the Company's cancer programs, which the Company expects will continue to grow throughout the second half of 2001. The Company also reported that it is currently reviewing comments made by the Food and Drug Administration (FDA) at a recent end-of-Phase II meeting for rNAPc2 for the prevention of deep vein thrombosis (DVT) and pulmonary embolism. The Company is working with the FDA to determine the nature, timing and anticipated costs of future clinical testing of rNAPc2. These events will delay the initiation of the next stage of clinical evaluation into 2002.>>

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next